Multiple Myeloma is a type of blood cancer that affects plasma cells, a specialized type of white blood cell responsible for producing antibodies. When these plasma cells become cancerous, they accumulate in the bone marrow, crowd out healthy blood cells, weaken bones, and may damage organs such as the kidneys.
Although Multiple Myeloma is a chronic blood cancer, significant advances in hematology, targeted therapy, immunotherapy, precision medicine, and Bone Marrow Transplant (BMT) have dramatically improved survival and quality of life.
If you are looking for the best Hematologist in Raipur or an experienced specialist for Multiple Myeloma Treatment in Raipur, Dr. Adamya Gupta offers personalized, evidence-based care using the latest international treatment protocols.
Multiple Myeloma develops when abnormal plasma cells multiply uncontrollably inside the bone marrow.
Instead of producing healthy antibodies, these abnormal cells produce ineffective proteins and interfere with normal blood cell production.
The disease commonly affects:
Without treatment, Multiple Myeloma can lead to fractures, infections, kidney damage, and anemia.
Early symptoms are often vague, causing delays in diagnosis.
Common symptoms include:
Pain in the back, ribs, hips, or spine is one of the earliest symptoms.
Bones become weak and may fracture easily.
Anemia caused by reduced red blood cell production often results in tiredness and weakness.
Abnormal plasma cells weaken the immune system.
Excess abnormal proteins produced by myeloma cells can damage the kidneys.
High calcium levels caused by bone destruction may lead to excessive thirst, constipation, and confusion.
The exact cause remains unknown.
Risk factors include:
Most patients have no identifiable cause.
Diagnosis requires several specialized investigations.
Blood tests help detect:
Urine examination may identify Bence Jones proteins produced by myeloma cells.
Bone marrow examination confirms the diagnosis and measures plasma cell involvement.
Doctors may recommend:
These help evaluate bone involvement and disease spread.
Advanced laboratory testing identifies high-risk genetic abnormalities that help guide personalized treatment decisions.
Treatment depends on disease stage, symptoms, genetic profile, and overall health.
Targeted medicines specifically attack myeloma cells while reducing damage to healthy tissues.
These drugs have transformed Multiple Myeloma treatment.
Modern immunotherapy enhances the body’s immune system to recognize and eliminate cancer cells.
New immunotherapy approaches continue to improve outcomes for many patients.
Chemotherapy may be combined with targeted therapies and steroids to control disease progression.
Corticosteroids remain an important part of many treatment protocols.
Eligible patients often benefit from Autologous Stem Cell Transplant, where their own healthy stem cells are collected and reinfused after high-dose chemotherapy.
This treatment can significantly prolong remission and improve long-term survival.
Multiple Myeloma is generally considered a chronic disease rather than a curable cancer.
However, modern therapies allow many patients to achieve:
Research continues to introduce newer and more effective treatment options.
Successful long-term management involves:
Close follow-up helps identify relapse early and optimize ongoing treatment.
Dr. Adamya Gupta specializes in comprehensive management of plasma cell disorders using advanced hematology techniques and personalized treatment planning.
His expertise includes:
Each patient receives an individualized treatment strategy based on disease biology, international guidelines, and the latest clinical evidence.
Most cases are not inherited, although a family history may slightly increase the risk.
While it is usually considered a chronic disease, modern treatments can achieve long-lasting remission and significantly improve survival.
No. Bone Marrow Transplant is recommended only for suitable candidates after careful evaluation.
Persistent bone pain, fatigue, recurrent infections, anemia, kidney problems, and fractures are among the most common early symptoms.
Multiple Myeloma is a complex blood cancer, but advances in targeted therapy, immunotherapy, precision medicine, and Bone Marrow Transplant have transformed patient outcomes. Early diagnosis and individualized treatment are essential for achieving the best possible quality of life and long-term disease control.
If you are looking for the best Hematologist in Raipur, best Hemato-Oncologist in Raipur, or expert Multiple Myeloma Treatment in Raipur, consult Dr. Adamya Gupta for comprehensive, compassionate, and evidence-based hematology care.
Every cancer journey is unique, and so is its treatment.
Book a consultation to receive personalized, evidence-based oncology care.
Blood diseases and blood cancer treatment in Raipur by Dr. Adamya Gupta, Hematologist & Hemato-Oncologist specializing in Bone Marrow Transplant.
Copyright © 2026 Dr Adamya Gupta via DCode-Astitva Media
